Korea Suspends Production Of 5 Janssen Products
This article was originally published in PharmAsia News
Executive Summary
Ending a two-week investigation into GMP deviations of J&J’s Korean unit, the Ministry of Food and Drug Safety orders a halt on manufacturing of five products.